SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-030709
Filing Date
2023-05-18
Accepted
2023-05-18 17:15:09
Documents
1
Period of Report
2023-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1556
  Complete submission text file 0001209191-23-030709.txt   3239
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Issuer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 6331 LAVENDALE AVE DALLAS TX 75230
Business Address
Herchuk Jannie Prestridge (Reporting) CIK: 0001973204 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34810 | Film No.: 23937110